Popular nasal decongestant doesn't actually relieve congestion, FDA experts say

United States News News

Popular nasal decongestant doesn't actually relieve congestion, FDA experts say
United States Latest News,United States Headlines
  • 📰 NYAmNews
  • ⏱ Reading Time:
  • 72 sec. here
  • 3 min. at publisher
  • 📊 Quality Score:
  • News: 32%
  • Publisher: 63%

The leading decongestant used by millions of Americans looking for relief from a stuffy nose is likely no better than a dummy pill, according to government experts who reviewed the latest research on the long-questioned drug ingredient.

Sign up for our acclaimed free newsletter Editorially Black with the top Racial Equity stories of the day to your inbox!

The FDA assembled its outside advisers to take another look at phenylephrine, which became the main drug in over-the-counter decongestants when medicines with an older ingredient — pseudoephedrine — were moved behind pharmacy counters. A 2006 law had forced the move because pseudoephedrine can be illegally processed into methamphetamine.

This week’s two-day meeting was prompted by researchers at the University of Florida, who petitioned the FDA to remove phenylephrine products based on recent studies showing they failed to outperform placebo pills in patients with cold and allergy congestion. The same researchers also , but the FDA allowed the products to remain on the market pending additional research.

“I feel this drug in this oral dose should have been removed from the market a long time ago,” said Jennifer Schwartzott, the patient representative on the panel. “Patients require and deserve medications that treat their symptoms safely and effectively and I don’t believe that this medication does that.” published ahead of this week’s meeting, which found numerous flaws with the 1960s and 1970s studies originally used to support phenylephrine’s approval.

A trade group representing nonprescription drugmakers, the Consumer Healthcare Products Association, argued that the new studies had limitations and that consumers should continue to have “easy access” to phenylephrine.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

NYAmNews /  🏆 269. in US

United States Latest News, United States Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Popular nasal decongestant doesn't actually relieve congestion, FDA experts sayPopular nasal decongestant doesn't actually relieve congestion, FDA experts sayGovernment advisers say the leading decongestant used by millions of Americans to treat nasal congestion doesn't actually work.
Read more »

Popular nasal decongestant doesn't actually relieve congestion, FDA experts sayPopular nasal decongestant doesn't actually relieve congestion, FDA experts sayGovernment advisers say the leading decongestant used by millions of Americans to treat nasal congestion doesn't actually work.
Read more »

Popular nasal decongestant doesn't actually relieve congestion, FDA experts sayPopular nasal decongestant doesn't actually relieve congestion, FDA experts sayGovernment advisers say the leading decongestant used by millions of Americans to treat nasal congestion doesn't actually work.
Read more »

Popular nasal decongestant doesn't actually relieve congestion, FDA experts sayPopular nasal decongestant doesn't actually relieve congestion, FDA experts sayGovernment advisors say a leading medication used by millions of Americans to treat nasal congestion doesn't actually work.
Read more »

Popular nasal decongestant doesn't actually relieve congestion, FDA experts sayPopular nasal decongestant doesn't actually relieve congestion, FDA experts sayGovernment advisers say the leading decongestant used by millions of Americans to treat nasal congestion doesn't actually work.
Read more »

FDA panel says this popular over-the-counter decongestant doesn't actually workFDA panel says this popular over-the-counter decongestant doesn't actually workIf the FDA follows through on the panel’s recommendations, Johnson & Johnson, Bayer and other drugmakers could be required to pull their oral medications containing phenylephrine from store shelves.
Read more »



Render Time: 2025-02-23 20:58:29